Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
The price for the Jazz Pharmaceuticals plc stock decreased slightly today. Compared to yesterday there is a change of -€0.200 (-0.140%).
With 38 Buy predictions and not a single Sell prediction Jazz Pharmaceuticals plc is an absolute favorite of our community.
With a target price of 173 € there is a slightly positive potential of 17.69% for Jazz Pharmaceuticals plc compared to the current price of 147.0 €.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | -0.140% | 4.284% | 0.344% | 12.260% | 1.143% | 6.435% | 8.993% |
| Repligen Corp. | -1.130% | 3.132% | -19.321% | -24.203% | -18.175% | -28.139% | -33.497% |
| Opko Health Inc. | 1.240% | -2.592% | -12.455% | -37.524% | -10.383% | 2.853% | -74.712% |
| Amicus Therapeutics Inc. | -1.650% | 0.833% | 0.000% | 41.520% | 0.833% | 1.544% | 21.000% |
Comments
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "buy" rating reaffirmed by analysts at TD Cowen.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Truist Financial Corporation from $220.00 to $230.00. They now have a "buy" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Needham & Company LLC from $210.00 to $235.00. They now have a "buy" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat